Skip to main content
Fig. 1 | Advances in Rheumatology

Fig. 1

From: COVID-19 on patients with immune-mediated rheumatic disease: a comparative study of disease activity, fatigue, and psychological distress over six months

Fig. 1

Comparison of disease activity scores across the three study visits (v1, V2 and V3) in patients with systemic lupus erythematosus, measured by the SLEDAI (A); rheumatoid arthritis, measured by the CDAI (B); and axial spondylarthritis patients, measured by the BASDAI, comparing cases and controls matched for sex, age and epidemiological exposure. V1: visit 1 (inclusion); V2: visit 2; V3: visit 3. CDAI: Clinical Disease Activity Score; SLEDAI: Systemic Lupus Erythematosus Disease Activity Index; BASDAI: Bath Ankylosing Spondylitis Disease Activity Index. One-way ANOVA (95% CI), repeated measures, multiple comparison of the mean of each column with the mean of every other column

Back to article page

Advances in Rheumatology

ISSN: 2523-3106